| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |